Trial Profile
Tolerability and pharmacokinetics of multiple ascending doses of bitopertin in male and female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Apr 2012
Price :
$35
*
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Roche
- 19 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 19 Apr 2012 New trial record